Greenbrook TMS (Greenbrook TMS) Common Stock : $121.24 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Greenbrook TMS Common Stock?

Greenbrook TMS's quarterly common stock increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($120.74 Mil) and increased from Dec. 2023 ($120.74 Mil) to Mar. 2024 ($121.24 Mil).

Greenbrook TMS's annual common stock increased from Dec. 2021 ($98.41 Mil) to Dec. 2022 ($114.12 Mil) and increased from Dec. 2022 ($114.12 Mil) to Dec. 2023 ($120.74 Mil).

Greenbrook TMS Common Stock Historical Data

The historical data trend for Greenbrook TMS's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenbrook TMS Common Stock Chart

Greenbrook TMS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

50.19

60.13

98.41

114.12

120.74

Greenbrook TMS Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															-	-	-	120.74	121.24

Greenbrook TMS Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Greenbrook TMS (Greenbrook TMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Greenbrook TMS Inc (OTCPK:GBNHF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

890 Yonge Street, 7th Floor, Toronto, ON, CAN, M4W 3P4

Website

https://www.greenbrooktms.com

Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.